Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03464461 · ClinicalTrials.gov registry record · Phase 4
Dosing of Ketorolac in the Emergency Department
A Phase 4 study, sponsored by University of Missouri-Columbia.
- Terminated
- Registry status
- Phase 4
- Development phase
- 289
- Enrollment target
NCT03464461 is a Phase 4 study that was terminated before completion, run by University of Missouri-Columbia. The registered enrollment target is 289 participants.
The verdict
NCT03464461, a Phase 4 study, was terminated before completion, sponsored by University of Missouri-Columbia.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 289 participants
- Enrollment target
Study Summary
The optimal dose of ketorolac in the Emergency Department setting is no clear. We will compare 3 doses to determine the optimal dose.
Interventions
- DRUG Ketorolac
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 289 participants |
| Start Date | 2018-05-01 |
| Est. Completion | 2024-05-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03464461
The ClinicalTrials.gov registry entry for NCT03464461 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 289 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Ketorolac is the first listed.
NCT03464461 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03464461 about?
NCT03464461 is a clinical study titled "Dosing of Ketorolac in the Emergency Department". The optimal dose of ketorolac in the Emergency Department setting is no clear. We will compare 3 doses to determine the optimal dose.
What is the current status of trial NCT03464461?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 289 participants. The study started on 2018-05-01. Estimated completion is 2024-05-30.
What interventions are being tested in trial NCT03464461?
The interventions under investigation include: Ketorolac (DRUG).
Who is sponsoring clinical trial NCT03464461?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.